Summit Trail Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.44M | Buy |
+40,020
| New | +$4.44M | 0.08% | 135 |
|
|
2024
Q4 | – | Sell |
-20,884
| Closed | -$1.75M | – | 527 |
|
|
2024
Q3 | $1.75M | Buy |
20,884
+3,779
| +22% | +$317K | 0.04% | 177 |
|
|
2024
Q2 | $1.17M | Buy |
17,105
+4,683
| +38% | +$321K | 0.03% | 216 |
|
|
2024
Q1 | $910K | Buy |
12,422
+65
| +0.5% | +$4.76K | 0.02% | 230 |
|
|
2023
Q4 | $1M | Sell |
12,357
-92
| -0.7% | -$7.45K | 0.03% | 178 |
|
|
2023
Q3 | $933K | Buy |
12,449
+444
| +4% | +$33.3K | 0.03% | 175 |
|
|
2023
Q2 | $925K | Buy |
12,005
+3,090
| +35% | +$238K | 0.03% | 182 |
|
|
2023
Q1 | $740K | Buy |
8,915
+3,000
| +51% | +$249K | 0.03% | 166 |
|
|
2022
Q4 | $508K | Sell |
5,915
-810
| -12% | -$69.5K | 0.02% | 184 |
|
|
2022
Q3 | $415K | Buy |
+6,725
| New | +$415K | 0.02% | 206 |
|
|
2021
Q4 | – | Sell |
-3,420
| Closed | -$239K | – | 303 |
|
|
2021
Q3 | $239K | Buy |
3,420
+283
| +9% | +$19.8K | 0.02% | 230 |
|
|
2021
Q2 | $216K | Sell |
3,137
-63
| -2% | -$4.34K | 0.02% | 200 |
|
|
2021
Q1 | $207K | Sell |
3,200
-353
| -10% | -$22.8K | 0.02% | 179 |
|
|
2020
Q4 | $207K | Buy |
+3,553
| New | +$207K | 0.03% | 176 |
|
|
2020
Q3 | – | Sell |
-2,658
| Closed | -$204K | – | 219 |
|
|
2020
Q2 | $204K | Buy |
+2,658
| New | +$204K | 0.04% | 151 |
|
|
2018
Q2 | – | Sell |
-7,808
| Closed | -$348K | – | 546 |
|
|
2018
Q1 | $348K | Buy |
7,808
+2,265
| +41% | +$101K | 0.06% | 246 |
|
|
2017
Q4 | $439K | Buy |
+5,543
| New | +$439K | 0.06% | 250 |
|